All In Biotech

Drug Trial Radar · NCT07465653

A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction

A Multi-center, Randomized, Participant- and Investigator- Blinded, Placebo-controlled Crossover Study to Investigate the Safety, Tolerability, and Pharmacokinetics of HJB647 in Participants With Chronic Stable Heart Failure With Reduced Ejection Fraction

Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

12

Planned (sponsor's estimate)

Start

Mar 18, 2026

Primary completion

Dec 8, 2026

Study completion Dec 8, 2026

Sponsor

Lead sponsor
Novartis PharmaceuticalsNovartis (NVS)
Sponsor type
Industry
First posted
Mar 12, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of HJB647 at two different doses in participants with chronic stable heart failure with reduced or mildly reduced ejection fraction (HFrEF/HFmrEF).

Conditions

  • Heart Failure With Reduced Ejection Fraction

Interventions

  • HJB647 low doseDrug

    Study drug low dose in capsule form

  • HJB647 high doseDrug

    Study drug high dose in capsule form

  • PlaceboOther

    Placebo control in capsule form

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants with Adverse Events (AEs)Time frame: Up to 33 days
  2. Number of participants with clinically significant changes in vital signsTime frame: Up to 33 days

Locations

7 sites in 2 countries. Site status is shown where the registry gives one.

  • Synergy Healthcare

    Bradenton, Florida · Recruiting

  • Nature Coast Clinical Research LLC

    Inverness, Florida · Recruiting

  • Jacksonville Center for Clinical

    Jacksonville, Florida · Recruiting

  • Inpatient Research Clinical LLC

    Miami Lakes, Florida · Recruiting

  • Flourish Research

    Winter Park, Florida · Recruiting

  • Novartis Investigative Site

    Montreal, Quebec, Canada · Recruiting

  • Novartis Investigative Site

    Sherbrooke, Quebec, Canada · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.